Genetic Cancer Therapy: The Growing Market for Hereditary Breast and Ovarian Cancer Syndrome Treatment
Genetic cancer therapy represents a paradigm shift in oncology, moving from a one-size-fits-all approach to highly personalized treatment based on an individual's genetic makeup. Hereditary breast and ovarian cancer syndrome (HBOC), caused by mutations in the BRCA1 and BRCA2 genes, is a prime example of how genetic insights are transforming cancer care. The market for genetic cancer...
0 Comentários 0 Compartilhamentos 75 Visualizações 0 Anterior